Pure Global AI
LMHRA DOC-GDL-017,

DOC-GDL-017, Version 01

Guidelines for Exemption of Fees Payment to the Authority for Certain Products and Services
LiberiaLiberia Medicines and Health Products Regulatory AuthorityRegistrationCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

DOC-GDL-017, Version 01 is the official LMHRA identifier for “Guidelines for Exemption of Fees Payment to the Authority for Certain Products and Services”. DOC-GDL-017, Version 01 is the official identifier LMHRA uses for this instrument.

Instrument
DOC-GDL-017,
Full name
DOC-GDL-017, Version 01
Category
Registration
Source links
Source publication
English
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Guidelines for Exemption of Fees Payment to the Authority for Certain Products and Services

Complete 12-page LMHRA DOC-GDL-017 guideline covers conditional exemption from LMHRA fees for specified products or services. Its health-product definitions expressly include medical devices and medical supplies; its separate orphan-medicinal-product conditions are retained without extending them to all devices. Eligibility evidence, application review, written decisions, non-transferability, monitoring and appeals are included. Ten business days concerns exemption-application review, not device registration or an import-tax waiver. The cover states issue 13 April 2026 and implementation 16 April, while the operative clause states immediate effect on Managing Director approval and the signed approval is dated 13 April; that discrepancy remains unresolved. The printed labelling TOC does not match the fee-exemption body and is preserved.

DOC-GDL-017, Version 01 is the official identifier LMHRA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.